International Clinical Trial: A 4-week, first in human study assessing the safety and tolerability of different doses of oral insulin (EA-Ins-IQ-100) in healthy volunteers

Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000827336) titled 'A 4-week, first in human study assessing the safety and tolerability of different doses of oral insulin (EA-Ins-IQ-100) in healthy volunteers' on July 9.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used) Assignment: Other Type of endpoint: Safety

Primary Sponsor: Endo Axiom Pty Ltd

Condition: Type 1 Diabetes Type 1 Diabetes Metabolic and Endocrine - Diabetes

Intervention: 12 participants will be randomly assigned to a unique placebo-controlled ascending dosing schedule in this study. Dosing will consist of 4 dosing days s...